Sodium benzoate attenuates 2,8-dihydroxyadenine nephropathy by inhibiting monocyte/macrophage TNF-α expression.

Sci Rep · 2023 · PMC9971245 · PMID 36849798

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may not be significantno p-value reported

The side effect may not be significant, although, long-term administration side effects should carefully be determined if applying to diseases including AdCKD and human CKD related to APRT deficiency in the future.

also in 2,774 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.